Adaptive Biotechnologies Corp

NASDAQ:ADPT   1:04:11 PM EDT
10.48
-0.69 (-6.18%)
Earnings Announcements

Adaptive Biotechnologies Reports Second Quarter 2022 Financial Results

Published: 08/03/2022 21:53 GMT
Adaptive Biotechnologies Corp (ADPT) - Adaptive Biotechnologies Reports Second Quarter 2022 Financial Results.
Q2 Revenue Rose 13 Percent to $43.7 Million.
Adaptive Biotechnologies Reiterates Full Year 2022 Revenue to Be in Range of $185 Million to $195 Million.
Now Expect Full Year 2022 Operating Expenses to Be Between $410 Million and $415 Million.
Revenue is expected to be $49.51 Million
Adjusted EPS is expected to be -$0.38

Next Quarter Revenue Guidance is expected to be $56.05 Million
Next Quarter EPS Guidance is expected to be -$0.38

More details on our Analysts Page.